Significant Ownership of PharmaCyte Biotech, Inc.

Signature - Title: /s/ Carlos Trujillo - Carlos Trujillo
Location: Las Vegas, NV
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by PharmaCyte Biotech, Inc..

Notify me when PharmaCyte Biotech, Inc. files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
QCLS	Q/C TECHNOLOGIES, INC.	Common Stock, par value $0.001 per share	74%	$28.6M		8.48M		PharmaCyte Biotech, Inc.	14 Nov 2025

Schedules 13D/G Reported by PharmaCyte Biotech, Inc.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.